Artiva Biotherapeutics (ARTV) Current Assets (2023 - 2026)
Artiva Biotherapeutics (ARTV) posted quarterly Current Assets of $88.7 million for Q1 2026, down 47.8% year-over-year from $170.0 million in Q1 2025, and down 21.24% quarter-over-quarter from $112.7 million in Q4 2025.
Artiva Biotherapeutics (ARTV) Current Assets (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has reported Current Assets for 4 consecutive years, with $88.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets fell 47.8% year-over-year to $88.7 million; the TTM figure through Mar 2026 stood at $88.7 million (down 47.8% YoY), while the FY2025 annual figure was $112.7 million, down 40.27% from the prior year.
- Current Assets fell to $88.7 million in Q1 2026 per ARTV's latest filing, from $112.7 million in the prior quarter.
- Across five years, Current Assets topped out at $188.6 million in Q4 2024 and bottomed at $49.7 million in Q2 2024.
- Historically, Current Assets has averaged $124.3 million across 4 years, with a median of $129.5 million in 2025.
- Annual changes were most pronounced in 2025 — Current Assets jumped 199.64% — and 2026, when it tumbled 47.8%.
- Artiva Biotherapeutics' Current Assets stood at $79.8 million in 2023, then soared by 136.32% to $188.6 million in 2024, then plunged by 40.27% to $112.7 million in 2025, then declined by 21.24% to $88.7 million in 2026.
- Business Quant data shows ARTV's Current Assets at $88.7 million in Q1 2026, $112.7 million in Q4 2025, and $129.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Artiva Biotherapeutics | 451.28 Mn | 451.28 Mn | - | 352.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 352.28 Mn |
| Mar 31, 2026 | 88.74 Mn |
| Dec 31, 2025 | 112.67 Mn |
| Sep 30, 2025 | 129.52 Mn |
| Jun 30, 2025 | 149.07 Mn |
| Mar 31, 2025 | 170.00 Mn |
| Dec 31, 2024 | 188.63 Mn |
| Sep 30, 2024 | 150.57 Mn |
| Jun 30, 2024 | 49.75 Mn |
| Dec 31, 2023 | 79.82 Mn |